Analyst consensus rating
Jade Biosciences Analyst Rating: Strong Buy
Direct answer
Jade Biosciences's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $49.38.
Forecast evidence checked November 14, 2026.
Get free Jade Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.14
- Average price target
- $49.38
- High price target
- $77.00
- Low price target
- $40.00
- Low target gap
- +147.8%
- Target upside
- +205.9%
- High target gap
- +377.1%
- Target range width
- 229.2%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Jade Biosciences?
Jade Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $49.38.
How far are Jade Biosciences's low and high targets from the recorded price?
The low target implies +147.8%, while the high target implies +377.1%.
How many analysts are included in Jade Biosciences's consensus?
The verified consensus includes 8 analysts.
How is Jade Biosciences's target upside or downside calculated?
The average target of $49.38 is divided by the recorded price of $16.14, then one is subtracted to produce +205.9%. This does not guarantee a future return.
When was Jade Biosciences's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.